Lupin Pharmaceuticals recalls Nystatin and Triamcinolone Acetonide Cream due to failed content uniformity tests at 9 months. This may affect product stability and safety for patients using prescription medication.
Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.
Take action
Contact the company
📍Recalling firmLupin Pharmaceuticals Inc.111 S Calvert St Fl 21ST · Baltimore, MD 21202-6174
“Lupin Nystatin Cream Recall: Failed Content Uniformity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38272-lupin-nystatin-cream-recall-failed-content-uniformity-risk. Based on FDA recall #D-1518-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1518-2019%22&limit=1).
The FDA announced on July 17, 2019, that Lupin Pharmaceuticals Inc. voluntarily recalled Nystatin and Triamcinolone Acetonide Cream USP due to failed content uniformity specifications. The recall affects 33,939 tubes distributed nationwide.
How to tell if you have it
Brand: Lupin
Product: Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only
NDC: 68180-545-01
Lot #: K800245 (Exp. Dec 2019), K900036 (Exp. Sep 20), K900153 (Exp. 09/2020)
The hazard
The product failed content uniformity specifications, with an out-of-specification result observed in the uniformity of containers test at the 9-month long-term stability condition for upright orientation.
Context
GovInfoNow's records show Lupin Pharmaceuticals Inc. has 90 other recalls on record since January 31, 2013. Other recent recalls by the brand include a Clobetasol Cream recall on August 3, 2026, and a Glucagon Emergency Kit recall on June 23, 2026. Other recent recalls of similar products include a Sun Pharmaceutical Fluocinonide Cream Recall on March 25, 2026, and a Padagis Nystatin Cream Recall on June 23, 2026.
How to tell if you have this one
Check for the product name 'Nystatin and Triamcinolone Acetonide Cream USP' with 15g tube size. It was manufactured by Lupin with specific lot numbers and expiration dates listed in the recall notice.
Brand
Lupin
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the product name, 15g tube size, and lot numbers (K800245, K900036, K900153) on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1518-2019 (July 17, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1518-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.